BIIB - Biogen Idec Inc. patents

This listing is of recent patents (patent applications) which may be related to Biogen Idec Inc. according to a patent app search. In *most* cases, they are listed under Biogen Idec Inc. because the company is listed in the Agent field of the patent application. Note: Biogen Idec Inc. (BIIB) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Biogen Idec Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Biogen Idec Inc. patents RSS Feed (FREE)

B

BA
BAX
BC
BDX
BEC
BHI
BIIB
BLC
BMRN
BMS
BMY
BRCD
BTH
BWA
BZ

Symbol	Company	Application #	Date	Title
BIIB	Biogen Idec	20120100575	20120426	Antibodies having altered effector function and methods for making the same
BIIB	Biogen Idec	20120100140	20120426	Stabilized fc polypeptides with reduced effector function and methods of use
BIIB	Biogen Idec	20120087925	20120412	Method for the treatment of inflammatory disorders
BIIB	Biogen Idec	20120083453	20120405	Treatment using neublastin polypeptides
BIIB	Biogen Idec	20120070437	20120322	Method of identifying compounds that bind baff-r
BIIB	Biogen Idec	20120064080	20120315	Human ly6-big molecules and methods of use
BIIB	Biogen Idec	20120058083	20120308	Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta
BIIB	Biogen Idec	20120053325	20120301	Purification of immunoglobulins
BIIB	Biogen Idec	20120039873	20120216	Antibodies against monocyte chemotactic proteins
BIIB	Biogen Idec	20120027751	20120202	Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
BIIB	Biogen Idec	20120022236	20120126	Recombinant anti-vla4 antibody molecules
BIIB	Biogen Idec	20120021484	20120126	Recombinant fcrn and variants thereof for purification of fc-containing fusion proteins
BIIB	Biogen Idec	20120020970	20120126	Methods of evaluating patients
BIIB	Biogen Idec	20120020913	20120126	Methods for pancreatic tissue regeneration
BIIB	Biogen Idec	20120014953	20120119	Treating and evaluating inflammatory disorders
BIIB	Biogen Idec	20120014960	20120119	Composition comprising antibodies to lingo or fragments thereof
BIIB	Biogen Idec	20120015024	20120119	Methods for treating tweak-related conditions
BIIB	Biogen Idec	20120015424	20120119	Arginine inactivation of viruses
BIIB	Biogen Idec	20120009178	20120112	Tweak binding antibodies
BIIB	Biogen Idec	20120003235	20120105	Anti-lymphotoxin antibodies
BIIB	Biogen Idec	20120003210	20120105	Neonatal fc receptor (fcrn)- binding polypeptide variants, dimeric fc binding proteins and methods related thereto
BIIB	Biogen Idec	20110311542	20111222	Sp35 antibodies and uses thereof
BIIB	Biogen Idec	20110311530	20111222	Truncated baff receptors
BIIB	Biogen Idec	20110305629	20111215	Anti-alpha v beta 6 antibodies and uses thereof
BIIB	Biogen Idec	20110301331	20111208	Stabilized polypeptide compositions
BIIB	Biogen Idec	20110293711	20111201	Utilization of dialkylfumarates
BIIB	Biogen Idec	20110293512	20111201	Compositions and methods for inhibiting growth of smad-4 deficient cancers
BIIB	Biogen Idec	20110281821	20111117	Modulators of mitotic kinases
BIIB	Biogen Idec	20110250200	20111013	Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
BIIB	Biogen Idec	20110244501	20111006	Cancer stem cells
BIIB	Biogen Idec	20110243966	20111006	Single chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
BIIB	Biogen Idec	20110236968	20110929	Humanized antibodies against monocyte chemotactic proteins
BIIB	Biogen Idec	20110189177	20110804	Antibodies to vla-1
BIIB	Biogen Idec	20110165159	20110707	Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant
BIIB	Biogen Idec	20110152260	20110623	Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
BIIB	Biogen Idec	20110147312	20110623	Automated system and method for monitoring chromatography column performance, and applications thereof
BIIB	Biogen Idec	20110135648	20110609	Anti-neublastin antibodies and uses thereof
BIIB	Biogen Idec	20110129468	20110602	Purified immunoglobulin fusion proteins and methods of their purification
BIIB	Biogen Idec	20110123535	20110526	Use of nogo receptor-1 (ngr1) for promoting oligodendrocyte survival
BIIB	Biogen Idec	20110123553	20110526	Use of lingo-4 antagonists in the treatment of conditions involving demyelination
BIIB	Biogen Idec	20110110950	20110512	Therapeutic regimens for baff antagonists
BIIB	Biogen Idec	20110059069	20110310	Gapr-1 methods
BIIB	Biogen Idec	20110052500	20110303	Taj in neuronal function
BIIB	Biogen Idec	20110002924	20110106	Tweak receptor agonists as anti-angiogenic agents
BIIB	Biogen Idec	20100330066	20101230	Methods for use with baff antagonists
BIIB	Biogen Idec	20100316706	20101216	Carbocyclic and oxacarbocyclic fumaric acid oligomers
BIIB	Biogen Idec	20100311189	20101209	Novel receptor nucleic acids and polypeptides
BIIB	Biogen Idec	20100284933	20101111	Biomarkers of multiple sclerosis
BIIB	Biogen Idec	20100272721	20101028	Treatment of cancer
BIIB	Biogen Idec	20100260761	20101014	Antibodies specifically reactive with a tumor necrosis factor related ligand
BIIB	Biogen Idec	20100202962	20100812	Cripto blocking antibodies and uses thereof
BIIB	Biogen Idec	20100203046	20100812	Fc gamma receptor-binding polypeptide variants and methods related thereto
BIIB	Biogen Idec	20100184951	20100722	Truncated baff receptors
BIIB	Biogen Idec	20100166757	20100701	Antibodies against monocyte chemotactic proteins
BIIB	Biogen Idec	20100136625	20100603	Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
BIIB	Biogen Idec	20100136000	20100603	Treatment of follicular lymphomas using inhibitors of the lt pathway
BIIB	Biogen Idec	20100130607	20100527	Neuroprotection in demyelinating diseases
BIIB	Biogen Idec	20100111952	20100506	Treatment of autoimmune disorders
BIIB	Biogen Idec	20100099608	20100422	Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
BIIB	Biogen Idec	20100093980	20100415	Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
BIIB	Biogen Idec	20100063020	20100311	Oral pharmaceutical formulations and methods for producing and using same
BIIB	Biogen Idec	20100061985	20100311	Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
BIIB	Biogen Idec	20100048488	20100225	Immunomodulatory peptides
BIIB	Biogen Idec	20100041032	20100218	Composition and methods for the detection of cripto-3
BIIB	Biogen Idec	20100040627	20100218	Baff receptor (bcma), an immunoregulatory agent

###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Biogen Idec Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Biogen Idec Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###